scispace - formally typeset
E

Eduardo Alegría-Barrero

Researcher at Universidad Francisco de Vitoria

Publications -  59
Citations -  1467

Eduardo Alegría-Barrero is an academic researcher from Universidad Francisco de Vitoria. The author has contributed to research in topics: MitraClip & Revascularization. The author has an hindex of 13, co-authored 56 publications receiving 1089 citations. Previous affiliations of Eduardo Alegría-Barrero include Imperial College London & Valve Corporation.

Papers
More filters
Journal ArticleDOI

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI

Justin E. Davies, +60 more
TL;DR: Coronary revascularization guided by iFR was noninferior to revascularizations guided by FFR with respect to the risk of major adverse cardiac events at 1 year.
Journal ArticleDOI

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.

Javier Escaned, +88 more
TL;DR: Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%.
Journal ArticleDOI

Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters.

TL;DR: The rate of strut malapposition was significantly reduced when OCT was used to confirm that wire recrossing was performed in a distal cell of the SB ostium.
Journal ArticleDOI

Optical coherence tomography: from research to practice

TL;DR: The use of OCT for assessment of lesion severity, characterization of acute coronary syndromes, guidance of intracoronary stenting, and evaluation of long-term results is reviewed.
Journal ArticleDOI

Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.

Oriol Rodríguez-Leor, +93 more
TL;DR: The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase inThe rate of in-hospital mortality.